跳至主要内容
临床试验/NCT04159480
NCT04159480已完成不适用

Facilitating Assessment of At-Risk Sailors Using Technology

VA Eastern Colorado Health Care System1 个研究点 分布在 1 个国家目标入组 279 人开始时间: 2019年12月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
279
试验地点
1
主要终点
Percentage of Cogito Participants Reported Being Satisfied

研究概览

简要总结

Randomized clinical trial with individuals being allocated to experimental (Cogito Companion) or Active Control arms. Those in the latter will receive information regarding widely available mobile self-help apps via a custom mobile app built in MyCAP. This same platform will be used to collect data regarding symptoms. Randomization will be stratified by gender, force (Surface, Aviation), and smartphone model (Android, I-Phone), as Cogito algorithms differ based on smartphone platforms. Participants will be willing Naval personnel being redeployed to CONUS. Data is also being collected (feasibility/acceptability) to inform future implementation..

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

盲法说明

Outcomes measures will be collected electronically

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Member of the Navel Surface or Aviation Forces;
  • •Age: 18-55 years at the time of enrollment;
  • •Ability to provide verbal and electronic informed consents;
  • •Ownership of smartphone;
  • •Willingness to use smartphone and personal data plan to participate.

排除标准

  • •Having redeployed (returning to the Continental United States) more than twelve months (approximately) prior to consent.
  • •Having an iPhone (until later in 2019 when the Cogito Corporation plans to release the iOS version of the Cogito Companion app).

研究组 & 干预措施

Experimental - Cogito Companion

Experimental

Those allocated to Experimental arm will have access the Cogito Companion for a three-month period post-consent. Passive data collection will also occur during this period. As a secure, privacy-compliant mobile app, the Cogito Companion facilitates the non-invasive collection, transfer, integration, analysis, and reporting of objective behavioral indicators. The Cogito mobile sensing platform passively gathers behavioral information through an individual's normal smartphone usage. Measurements of location, call, and text patterns are recorded.

干预措施: Experimental - Cogito Companion (Device)

Active Control

Active Comparator

Participants randomized to the Active Control group will download MyCAP and have access to resources housed within this app for a three-month period post-consent. Participants will be provided information regarding the mHealth Tool apps, and provided basic information on how to download the apps. As noted above, participants will be provided biweekly surveys .

干预措施: Active Control (Behavioral)

结局指标

主要结局

Percentage of Cogito Participants Reported Being Satisfied

时间窗: From Baseline to Follow-Up, Approximately 3 months

To measure the percentage of participants randomized to Cogito who were satisfied, a 'Client Satisfaction Questionnaire' was distributed to participants to complete and return. Responses were collected and evaluated to find the percentage of participant satisfaction.

次要结局

未报告次要终点

研究者

申办方类型
Fed
责任方
Principal Investigator
主要研究者

Lisa Brenner

Investigator

VA Eastern Colorado Health Care System

研究点 (1)

Loading locations...

相似试验